Lunai Bioworks gives notice of Nasdaq delisting

Lunai Bioworks Inc. submitted a Form 25 notification concerning removal of its Common Stock, par value $0.0001 per share, from listing and/or registration on The Nasdaq Stock Market LLC.

Accepted by SEC EDGAR 11/02/2026 - 12:00 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Lunai Bioworks Inc. submitted a Form 25 notification concerning removal of its Common Stock, par value $0.0001 per share, from listing and/or registration on The Nasdaq Stock Market LLC. The notification refers to both the exchange procedure for striking a class from listing and the issuer procedure for voluntary withdrawal.

Key Figures

Common Stock par value: $0.0001 per share

1 metrics

Common Stock par value $0.0001 per share Lunai Bioworks Inc. Common Stock

Key Terms

par value, strike the class of securities from listing, voluntary withdrawal

3 terms

par value financial

"Common Stock, par value $0.0001 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

strike the class of securities from listing regulatory

"rules to strike the class of securities from listing"

voluntary withdrawal regulatory

"governing the voluntary withdrawal of the class"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-38758

Lunai Bioworks Inc. / The Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

3400 Cottage Way, Suite G2, #32562, Sacramento, California 95825; (424) 222-9301

(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

Common Stock, par value $0.0001 per share

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

☐ 17 CFR 240.12d2-2(a)(1)

☐ 17 CFR 240.12d2-2(a)(2)

☐ 17 CFR 240.12d2-2(a)(3)

☐ 17 CFR 240.12d2-2(a)(4)

☐ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.^[1]

☒ Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

 ^[1]Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Pursuant to the requirements of the Securities Exchange Act of 1934, Lunai Bioworks Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

November 2, 2026	By: /s/ David Weinstein	David Weinstein	Chief Executive Officer
Date		Name	Title